Armata Pharmaceuticals, Inc.
ARMPAMEXHealthcare● Active
$7.56
+$0.06(+0.80%)
Market Cap$277533648
P/E Ratio—
52W High$16.34
52W Low$1.74
Armata Pharmaceuticals, Inc. (ARMP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ARMP · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $4.90M | $5.17M | $4.53M | $5.51M | $4.47M |
| Cost of Revenue | $1.53M | $34.43M | $0.97M | $35.02M | $20.02M |
| Gross Profit | $3.37M | ($29.25M) | $3.56M | ($29.51M) | ($15.54M) |
| Gross Margin %(computed) | 68.78% | -565.37% | 78.54% | -535.75% | -347.36% |
| Operating Expenses | |||||
| R&D Expenses | $23.72M | $34.43M | $33.77M | $35.02M | $20.02M |
| G&A Expenses | $12.41M | $13.18M | $0.00M | $7.44M | $8.28M |
| Total Operating Expenses | $34.59M | $13.18M | $44.45M | $7.44M | $8.28M |
| Operating Income | ($31.22M) | ($42.44M) | ($40.89M) | ($36.95M) | ($23.82M) |
| Operating Margin %(computed) | -636.66% | -820.18% | -902.85% | -670.77% | -532.45% |
| Interest Income | $0.39M | $0.70M | $0.18M | $0.03M | $0.01M |
| Interest Expense | $16.59M | $10.74M | $2.63M | $0.03M | $0.06M |
| Income Before Tax | ($173.80M) | ($18.92M) | ($69.05M) | ($36.92M) | ($23.16M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($173.80M) | ($18.92M) | ($69.05M) | ($36.92M) | ($23.16M) |
| Net Margin %(computed) | — | -365.60% | — | -670.24% | -517.55% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.80 | $-0.52 | $-1.91 | $-1.08 | $-0.96 |
| Wtd Avg Shares | 36.24M | 36.16M | 36.08M | 34.29M | 24.10M |
| EBITDA | ($29.69M) | ($41.11M) | ($65.45M) | ($36.05M) | ($21.92M) |
| EBITDA Margin %(computed) | -605.44% | -794.57% | — | -654.58% | -489.99% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Armata Pharmaceuticals, Inc. data
About Armata Pharmaceuticals, Inc. (ARMP) Income Statement
Armata Pharmaceuticals, Inc. (ARMP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ARMP reported revenue of $0.00B, gross profit of $0.00B (gross margin 68.78%), and net income of ($0.17B) — a net profit margin of -3544.03%.
Frequently asked questions
ARMP · 4 questionsArmata Pharmaceuticals, Inc. (ARMP) reported revenue of $0.00B for 2025, down 5.2% year-over-year.
ARMP revenueARMP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08